Myocardial contrast echo: current status and future directions

Area of Science:

• Cardiovascular Imaging
• Medical Ultrasound
• Diagnostic Technologies

Background:

• Contrast echocardiography (CE) has evolved significantly since its inception in the late 1960s.
• Early work by Joyner and Gramiak & Shah established foundational principles for enhanced echocardiographic imaging.
• The modality has transitioned from purely diagnostic to incorporating therapeutic applications.

Purpose of the Study:

• To review the historical development and current applications of contrast echocardiography.
• To highlight the evolution of CE from a diagnostic tool to a therapeutic modality.
• To discuss the potential and limitations of CE in tissue-level assessment, vascular inflammation, and drug delivery.

Main Methods:

• Historical review of contrast echocardiography literature.
• Analysis of key milestones and technological advancements.
• Discussion of current and emerging applications in clinical practice.

Main Results:

• Contrast echocardiography has expanded its role beyond diagnostics to therapeutics.
• It serves as a valuable tool for assessing myocardial perfusion (MPI) at the tissue level.
• Applications include specialized uses in vascular inflammation and targeted drug delivery.

Conclusions:

• Contrast echocardiography is a versatile imaging modality with a growing therapeutic scope.
• Ongoing advancements in imaging software and microbubble agents are continuously improving its efficacy.
• Technical challenges in image acquisition and microbubble physics remain areas for future development.